---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-044751"
form_type: "8-K"
ticker: "NKTR"
cik: "0000906709"
company_name: "NEKTAR THERAPEUTICS"
filed_at: "2026-02-10T23:59:59+00:00"
generated_at: "2026-05-16T03:46:49.948660+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Nektar Therapeutics reports $229.1M cash and investments as of Jan 31, 2026

## Summary
- Cash and marketable securities totaled approximately $229.1 million as of January 31, 2026.
- Announcement made on February 10, 2026 via a Regulation FD disclosure.
- The amounts are estimates based on information available as of the announcement date.
- Nektar Therapeutics (ticker: NKTR) listed on the Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001193125-26-044751
- form_type: 8-K
- ticker: NKTR
- cik: 0000906709
- company_name: NEKTAR THERAPEUTICS
- filed_at: 2026-02-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/906709/000119312526044751/0001193125-26-044751-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/906709/000119312526044751/d40599d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-044751
- JSON: https://secwatch.observer/filing/0001193125-26-044751.json
- Plain text: https://secwatch.observer/filing/0001193125-26-044751.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.